India’s Second Stab At Whistle Blower Policy To Curb Spurious Drug Trade
This article was originally published in PharmAsia News
Executive Summary
India is making renewed efforts to encourage whistle blowers to share leads and help weed out spurious drugs from the Indian market while blocking exports of such consignments.